Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Umanzor-Figueroa C"'
Autor:
Harvey E; Clinical R&D, F2G, Ltd, Manchester, UK., Clegg J; Clincial Outcomes Assessments, Clinical Outcomes Solutions, Chicago, IL, USA., Bresnik M; Clinical R&D, F2G, Ltd, Manchester, UK., Blatt E; Clincial Outcomes Assessments, Clinical Outcomes Solutions, Chicago, IL, USA., Hughes S; Clinical Outcomes Assesments, Clinical Outcomes Solutions, Folkestone, Kent, UK., Umanzor-Figueroa C; Clincial Outcomes Assessments, Clinical Outcomes Solutions, Chicago, IL, USA., Purdie R; Patient Coordination, Valley Fever Institute at Kern Medical, Bakersfield, CA, USA.; MyCology Advocacy, Research and Education (MyCARE), Colorado Springs, CO, USA., Thompson GR 3rd; Division of Infectious Diseases, Department of Internal Medicine, UC Davis Health, Sacramento, CA, USA., Symonds T; Clinical Outcomes Assesments, Clinical Outcomes Solutions, Folkestone, Kent, UK.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Dec 17. Date of Electronic Publication: 2024 Dec 17.
Autor:
Broderick L; QualityMetric, Johnston, Rhode Island, USA., Chen WH; GSK, Value Evidence and Outcomes, Collegeville, Pennsylvania, USA., Levy RA; GSK, Global Medical Affairs, Collegeville, Pennsylvania, USA., Mitchell Foster A; QualityMetric, Johnston, Rhode Island, USA., Umanzor Figueroa C; QualityMetric, Johnston, Rhode Island, USA., Gairy K; GSK, Value Evidence and Outcomes, Brentford, Middlesex, UK., Chauhan D; GSK, Value Evidence and Outcomes, Brentford, Middlesex, UK.
Publikováno v:
Journal of health economics and outcomes research [J Health Econ Outcomes Res] 2023 Aug 18; Vol. 10 (2), pp. 30-38. Date of Electronic Publication: 2023 Aug 18 (Print Publication: 2023).